User:Mr. Ibrahem/Fondaparinux

Fondaparinux, sold under the brand name Arixtra, is an anticoagulant used to treat and prevent blood clots (deep vein, pulmonary, and superficial vein thrombosis) and to treat unstable angina and heart attacks. It is given by injection under the skin.

Common side effects include bleeding. Other side effects may include low platelets. Use is not recommended in those with serious kidney problems. There is no evidence of harm to the baby with use in pregnancy. It works by blocking factor Xa.

Fondaparinux was approved for medical use in the United States in 2001 and Europe in 2002. It is available as a generic medication. In the United Kingdom 2.5 mg costs the NHS about £6. In the United States this amount costs about 20 USD.